Navigation Links
AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
Date:11/5/2013

REDWOOD CITY, Calif., Nov. 5, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX),  a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and nine months ended September 30, 2013.

"With the submission of our NDA at the end of September for Zalviso™, AcelRx has commenced activities related to an anticipated U.S. commercial launch," stated Richard King, president and CEO of AcelRx.  "We also continue to actively participate in key medical meetings worldwide to increase awareness of the results from our completed Zalviso Phase 3 clinical trials among a broad audience of medical professionals involved in pain treatment.  Having appointed our Chief Commercial Officer last quarter, we are working diligently to prepare Zalviso to be well positioned for launch in the US market, subject to regulatory approval."

Third Quarter and Nine Months Financial ResultsNet loss for the third quarter of 2013 was $11.0 million, or $0.26 per share, compared with a net loss of $8.6 million, or $0.38 per share for the third quarter of 2012.  The adjusted net loss for the third quarter of 2013 was $8.6 million, or $0.21 per share and excludes a $2.4 million non-cash expense resulting from the liability accounting related to warrants issued in connection with the PIPE financing completed in June 2012.  There was no such expense recorded in the third quarter of 2012.

During the third quarters of 2013 and 2012, AcelRx recognized revenue of $0.5 million and $0.2 million, respectively, as reimbursement for work completed under a research grant from the U.S. Army Medical Research and Materiel Command, or USAMRMC, for development of ARX-04, a sufentanil NanoTab product candidate for the treatment of moderate-to-severe acute pain
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
2. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
3. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
4. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
5. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
6. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
7. AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
8. AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
9. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
10. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
11. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx ... today announced a peer-reviewed publication of the results ... evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for the ... controlled adverse environment (CAE ® ) model.  The ... the results, which were previously disseminated by the ...
(Date:5/22/2015)... 2015 Research and Markets ( ... "Latest Regulations on Pharmaceutical International Multi-Center Clinical ... This is first time in history, ... international multi-center clinical trials of drugs in ... be implemented on March 1, 2015. The guidance ...
(Date:5/22/2015)... 2015  China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... resignation of Mr. Fuxiang Zhang as the ... Ms. Rebecca Yingnan Zhang has been appointed ... directors, effective immediately. Meanwhile, Ms. Zhang resigned from the ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3
... Dec. 16, 2011  Ampio Pharmaceuticals, Inc. (Nasdaq: ... discovers and develops new uses for previously approved drugs ... to recent publications about the Company by anonymous short ... its common stock is a result of factually inaccurate ...
... 16, 2011 Eli Lilly and Company (NYSE: ... Thursday, January 5, 2012 and, separately, will announce its financial ... on Tuesday, January 31, 2012.  On each day, Lilly will ... to further detail the company,s 2012 financial guidance and its ...
Cached Medicine Technology:Ampio Responds to Recent Publications by Anonymous Short Sellers 2
(Date:5/24/2015)... 25, 2015 Pacific Prime has announced that they ... looking at the cost of individual international health insurance. Titled: ... looks at the cost of health insurance in six top expat ... Hong Kong , Singapore , ... UAE , the UK , Article 2 ...
(Date:5/24/2015)... 2015 Scientists with Cardno ChemRisk, a ... quality compliance issues that may have raised the risk ... has just posted an article on the research. ... group found airborne asbestos levels well above OSHA safety ... and 2011. , “Asbestos compliance sampling data associated with ...
(Date:5/24/2015)... 24, 2015 Medicx Media Solutions ... strategy executive Jay Krihak as its head of ... ramp up its expertise and leadership position in ... and Health sectors. , Krihak is an experienced, ... recently, Krihak led sales planning teams for mobile ...
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... 23, 2015 A live auction will be ... hospitals, surgery centers and other medical facilities around the United ... endoscopy, lab, radiology, surgery, anesthesia, exam and much more. ... and Thursday, May 28 starting at 9:00am CDT each day. ... N. 25th Avenue, Melrose Park, IL 60160. Anyone can ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... implanted in the eye during cataract surgery have led ... a common form// of farsightedness that typically develops in ... School urges people considering this operation to weigh its ... recently developed implantable variable-focus lenses, which enable people to ...
... courthouse in New Jersey was closed following the diagnosis of ... remain shut at// least until Monday. ,State and ... partly due to privacy rules. The woman’s condition has been ... independent title searcher with the Mercer County clerk's office. ...
... Pradesh will soon get calorie-rich and varied midday meals.// ... the state were being served 'khichdi' six times a week ... the menu drab. ,"Now the government has chalked ... vegetables and even an occasional serving of dry fruit," said ...
... seven students at Wheaton College and has caused affected students ... September 7. Mumps causes// swollen glands close to the jaw ... we have a good handle on things, and we are ... for the DuPage County Health Department. "We feel that Wheaton ...
... Pharmaceuticals has announced that exenatide is very effective in ... aspart 30/70 (NovoMix by NovoNordisk). This finding was revealed after ... a boon to people suffering type 2 diabetes and unable ... , ,The study, which spanned a year, ...
... foeticide in Kerala have come as a surprise to politicians ... literacy rate.// ,"The number of girls in the 0-6 ... happened just because of female feticide and nothing else. The ... is happening and who are the guilty," said Health Minister ...
Cached Medicine News:
... modular cleanroom for biological safety labs ... cleanliness (to Class 10/ISO 3) and ... create ultra-smooth surfaces that are easy ... radius corners simplify cleaning. Unique double-wall ...
Inquire...
... want a floor model centrifuge to do, but ... , PR-7000M delivers up to 50% more force ... done faster and more efficiently., Tremendous Capacity ... 6 liters, PR-7000M accommodates 30 microplates, up to ...
Inquire...
Medicine Products: